Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMolecular ImagingPSMA PET-guided radiotherapy shows promiseA trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.Practice ManagementContrast media-reduction strategies could curb emissions up to 53%Practice ManagementDoes CMS 2026 proposed rule enforce efficiency at a cost to practices?Womens ImagingMissed previous mammography screening linked to worse disease outcomesSponsor ContentDigital Innovations Shaping the Future of Radiology
